Sort
21,453 grants matching “tuberculosis”
Characterization of Mycobacterial Sigma Factors
$316,000Children'S Hospital Boston · R01 · FY2004 · AI
NUTRITION, IMMUNOLOGY, AND EPIDEMIOLOGY OF TB
$315,966Harvard University (Sch Of Public Hlth) · U01 · FY2000 · AI
Studies of Inherited Causes of Fungal Susceptability
$315,915Sergio Rosenzweig · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Structure and Function of RNA Polymerase in E.coli
$315,900Arkady Mustaev · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2008 · GM
Identifying CMV Retinitis as a Reversible Cause of Vision Loss in Persons with HIV-associated Meningitis
$315,883Caleb P Skipper · University Of Minnesota · R21 · FY2023 · EY
Using Small Compounds as Probes for Studying Mechanosensitive Channel Gating
$315,865Paul L Blount · Ut Southwestern Medical Center · R01 · FY2019 · GM
Using Small Compounds as Probes for Studying Mechanosensitive Channel Gating
$315,865Paul L Blount · Ut Southwestern Medical Center · R01 · FY2018 · GM
Using Small Compounds as Probes for Studying Mechanosensitive Channel Gating
$315,865Paul L Blount · Ut Southwestern Medical Center · R01 · FY2020 · GM
Chemoenzymatic studies of aminoglycoside-resistance enzymes towards new drugs
$315,788Sylvie Garneau-Tsodikova · University Of Michigan At Ann Arbor · R01 · FY2012 · AI
Recognition of Mtb-infected Cells by CD8+ T Lymphocytes
$315,746David M. Lewinsohn · Oregon Health & Science University · R01 · FY2008 · AI
Project 3: Arsenic Biomarker Epidemiology
$315,724Martyn T Smith · University Of California Berkeley · P42 · FY2016 · ES
Mass Spectrometer for Small Molecule Drug Development
$315,651Bernd Meibohm · University Of Tennessee Health Sci Ctr · S10 · FY2014 · OD
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM
$315,614Audrey Ragan Odom John · Washington University · R01 · FY2013 · AI
Genetic Approaches for Improving Tuberculosis Vaccines
$315,517William Robert Jacobs · Albert Einstein College Of Medicine · P01 · FY2008 · AI
Virulence of the Opportunistic Pathogen Rhodococcis Equi
$315,485Mary Hondalus · University Of Georgia · R01 · FY2009 · AI
Virulence of the Opportunistic Pathogen Rhodococcis Equi
$315,485Mary Hondalus · University Of Georgia · R01 · FY2008 · AI
Immunology Training Program-Predoctoral
$315,440Brian A Cobb · Case Western Reserve University · T32 · FY2022 · AI
Animal Models Core
$315,412Randall J Basaraba · Brigham And Women'S Hospital · U19 · FY2020 · AI
Second Generation InSTIs for the Treatment of HIV-1 in patients with TB co-infection on Rifampicin-based Treatment in KwaZulu Natal, South Africa
$315,411Anushka Naidoo · Centre/Aids Programme/Res/South Africa · R01 · FY2022 · AI
Functional Studies of Granulocyte Membranes
$315,410Elizabeth R Simons · Boston University Medical Campus · R01 · FY2006 · HL
Non-invasive diagnosis of adult pulmonary tuberculosis
$315,387Gerard A Cangelosi · University Of Washington · R01 · FY2021 · AI
Molecular-genetic analysis of TB persistence and latency
$315,373Rockefeller University · R01 · FY2004 · AI
OPP-PRF: Demographic, Epidemiologic, and Social Consequences of the 1918 Influenza Pandemic in Alaska
$315,337Taylor Van Doren · University Of Alaska Anchorage Campus · · FY2023 · GEO
Celecoxib Derivative: Host Cell-Directed Inhibitors of Intracellular Pathogens
$315,308Kristy M Ainslie · Univ Of North Carolina Chapel Hill · R33 · FY2015 · AI
Immune control of tuberculosis by IFN-gamma-inducible LRG-47
$315,294John D Macmicking · Yale University · R01 · FY2008 · AI